The U.S. Black population is 12.4%, and at ChristianaCare, 32% of the heart failure patient population is Black — a race that has historically experienced healthcare disparities for heart failure treatment, including low adherence to guideline-directed medical therapy.
To counteract rates of substandard care, ChristianaCare locked arms with health technology company Story Health, the Newark, Del.-based system said in a Feb. 23 news release.
With Story Health, the system launched a digital platform that offers a health coach who helps with medication adherence, coordinates lab work and aids patients with transportation and prescription assistance.
Here are the collaboration’s results:
- Six times improvement on target doses of beta blockers (76%)
- Seven times improvement on target doses of angiotensin converting enzyme inhibitors, angiotensin receptor blockers and angiotensin receptor neprilysin inhibitors (54%)
- Two times improvement on target doses of mineralocorticoid receptor antagonists (57%)
- Increase in sodium-glucose cotransporter 2 inhibitor adherence, rising from a 32% baseline to 74%
- Decrease in average absolute systolic and diastolic blood pressure levels after 120 days
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
